Saturday, October 22, 2011

2011 MCL Symposium

Anyone who had read this blog should know of the admiration, respect and gratitude I have towards Dr. Goy so when I received a phone call from one of his Research Nurses the other night, inviting me to the “2011 MCL (Mantle Cell Lymphoma ) Symposium” I immediately said “YES, I will be there!”.

This great event will be held on: Saturday, November 12, 2011 at The John Theurer Cancer Center in Hackensack, New Jersey and it will include experts from all over the world sharing their view of what the future looks like for Mantle Cell Lymphoma survivors like us.


So when you read: 
“Join Us as Internationally-Recognized Experts Share the Latest in Treating and Managing Mantle Cell Lymphoma
 Does this interest you? If it does, here is what the day will include:


2011 MCL Symposium Agenda: Saturday, November 12, 2011

8:00 AM to 3:30 PM

·         Complimentary registration, breakfast and lunch
SYMPOSIUM AGENDA
8:00 - 8:30 AM
·         Gathering & healthy continental breakfast buffet with smoothie station
8:30 - 8:40 AM Andre Goy, M.D., M.S., Chairman and Director of The John Theurer Cancer Center.
·         Opening remarks and introductions.
8:40 - 9:40 AM Elias Campo,M.D., Ph.D University of Barcelona, Spain
·         Understanding the Biology and Prognostic Markers of MCL. Stratification of patients by genetic and biological markers. Update on the identification of new targets for therapy and the potentials of tailoring treatments to individual patient needs.
9:40 - 10:40 AM Jorge E. Romaguera, M.D.M.D., Anderson Cancer Center, Houston, TX
·         R-Hyper-CVAD, conventional and emerging frontline chemotherapy regimens for both younger/fit patients and for older, or transplant ineligible, patients. The emerging role of consolidation and maintenance therapies in management of MCL
10:40—10:55 AM
·         Coffee Break
10:55 - 11:55 AM Christian Geisler. M.D., Ph.D. Rigshospitalet, Copenhagen, Denmark
·         Impact of high dose frontline therapy with autologous stem cell transplant on outcome: the Nor-dic Group’s experience. Molecular remission and the potential benefits of monitoring minimal residual disease after complete molecular
11:55 - 12:40 PM
·         Lunch
12:40 – 1:40 PM Scott Rowley, M.D. John Theurer Cancer Center, Hackensack, NJ
·         Options for Relapse or Refractory MCL. Are autologous stem cell transplants better in a frontline setting? Progress & the role of the mini-allo, or reduced intensity,non-myeloablative allogeneic transplant.
1:40 - 2:40 PM Andre Goy, M.D, M.S. John Theurer Cancer Hackensack, NJ
·         Toward Cure and Less Toxic Treatment: Emerging and Novel Therapies for MCL. Exciting new directions and the most promising targeted treatments – single and combination therapies – cur-rently in development and clinical trials.
2:40 - 3:10 PM David Miller, 9-year MCL Survivor, Aspen, CO
·         Perspectives from an Expert Patient and Long-Term Survivor. Optimizing survival and health through healthy lifestyle and cutting edge nutrition. What is the role of the informed patient from diagnosis through long-term survivorship? The best ways to become an informed patient. Opti-mizing communication with your oncologist and becoming a valuable member of your healthcare team. Is a clinical trial right for me?
3:10 - 3:30 PM
·         Farewell remarks

If you are interested in attending or learning more about this event please see below:
Registration: 
 For more information or to register please email Ms. Ewelina Jakubowska at:
ejakubowska@humed.com 
or call at 201-996-4469

You can also register online at: 

  

The John Theurer Cancer Center is located at: 92 Second Street, Hackensack NJ 07601


 
I plan to post my next update after I get the results from my next scans which are scheduled for December 12th with me getting the results on December 16th. Of course if I have any news to report I will enter an update sooner. 
 




3 comments:

Amy said...

I would love to find a replay or any written info from the conference. My mom was just diagnosed and weare in education mode. With how fast things are changing, I look forward to your perspective.

Rich Franco said...

Hi Amy. I do not have access to a site that contains the notes and or a recoding of the session. I would suggest that you contact the John Theurer Cancer Center directly. Their contact info is:
92 Second Street, Hackensack, New Jersey 07601 | 201-996-5900.
The person who contacted me that may be able to assist you is: Ewelina Jakubowska and her email is:ejakubowska@humed.com

Lastly, reaching out to someone on Dr. Andre Goy's staff will surely get you a great deal of information. Here is a link to him on the JT Cancer Center Site:
http://www.jtcancercenter.org/physicians/find_a_specialist/division_chiefs1/andre_goy_m.d._m.s1/

From a patient's perspective I will say that I put my life in the hands on Dr. Goy and he truly did very well by me. I was in a study that had 18 people and 17 of us are still in remission. Treatments have come a very long way. When I first was diagnosed the postings on the internet were very grim. When you check the internet today the postings are trending to be much more positive. I am confident that your mom will do great. Best of luck and I will add your mom to prayers for my ever growing MCL Survivor Family.

Rich

John Lauber said...

I just finished my rituxan/treanda 6 course treatment in November and tomorrow, Dec. 13th, I go for a PET scan and bone marrow biopsy. I would have liked to attend the symposium but I believe I will have opportunities to attend future gatherings of that type.